Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
about
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesUtility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.Insulin secretion and insulin-producing tumors68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.Enhanced cholinergic response in pancreata of nonhuman primates with impaired glucose tolerance shown on [18F]fluorobenzyltrozamicol positron emission tomographyDual radiotracer analysis of cholinergic neuronal changes in prediabetic mouse pancreasRare and unusual endocrine cancer syndromes with mutated genes.99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis.Metastatic insulinoma - prolonged survival after multimodal approachEnzyme inhibition of dopamine metabolism alters 6-[18F]FDOPA uptake in orthotopic pancreatic adenocarcinoma.Giant insulinoma in a 15-year-old man: A case reportLocalization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imagingHypoglycaemia in a patient who is non-diabetic.Molecular imaging of neuroendocrine tumorsNordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their typeRole of (18) F-FDOPA PET/CT imaging in endocrinology.18F-FDOPA PET/CT imaging of insulinoma revisited.Diagnostic tools for post-gastric bypass hypoglycaemia.Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery.Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance.Cross sectional and nuclear medicine imaging of pancreatic insulinomas.Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications.Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.Single incision laparoscopic 90 % pancreatectomy for the treatment of persistent hyperinsulinemic hypoglycemia of infancy.6-[18F]fluoro-L-DOPA uptake in the rat pancreas is dependent on the tracer metabolism.Characteristics and Outcomes of 79 Patients with an Insulinoma: A Nationwide Retrospective Study in Finland
P2860
Q24647838-D39FF0F0-302D-46DD-83F2-8224CCA1AE1DQ33738687-C18BE1C4-7622-4BE8-BEEC-A707429C8C65Q33786707-20533060-54C7-4283-AFC6-A072744BA026Q33915233-05870122-24F4-482E-9832-8F49524543A5Q33985583-39D260DF-D089-4CA1-A7A2-E0AF32E94D60Q34302234-FFC32B83-B302-48E1-9F3D-40E002F3A779Q34645240-E7F53ED6-CA6E-4DD8-98F2-C0A5100A10D0Q36104200-ADE51431-2394-4347-B4FC-F493B9B2882BQ36433556-739ECFE0-5742-4714-A9F8-A3DFE7A16303Q36516682-9EB7A110-3286-42F5-B013-E3700D9DDC3EQ36744866-1BADE056-BA11-40B5-9CF7-49D7ABC9E3CBQ36984779-786A1BE4-E947-4AD0-B1D1-5E91909205DCQ37193173-A13E783B-734E-45D2-9159-29345ACA68F0Q37273065-C6C7EC4C-2EE1-4B5F-89A4-FFFC19F319EEQ37656835-1F70F670-646D-4A9F-82E8-D2F9A0150EB0Q37730951-5296ACC0-92F4-4329-85D2-EB80B68400B7Q37765569-29241081-9557-4DB0-9F89-04669CD3B6EEQ38082417-AD8E0389-70FA-476F-8A7A-F5F70A0EF015Q38233342-90EA8940-C879-445B-B588-A11B5C339439Q38264851-BB7BD030-1C28-4DA8-A50F-A517DBD69CD7Q38575581-9FB90746-D5CC-417F-AE2D-3C9F01FA18BEQ38621964-7DD104FF-469C-45BB-8EF3-F84D06D31DB7Q38636001-220A6722-97CC-4ABC-9447-0D67D3C600CEQ38957569-C4411D56-18DA-4A62-AB40-9C9DE46A4EC5Q42392588-F3F2FC28-D68B-4F6A-A0C0-843A72351C2EQ46798932-63510BDF-E5A1-4593-A881-11138D436671Q48089118-ACE162C4-D94E-459D-83C1-5FCBF748DD9BQ51281044-84037D5E-2E5C-4D71-9F03-68B7DCDDD0D9Q54621041-36BAE134-B69C-4640-82A7-B5E47EB2B031Q58693664-012F66D2-23A8-4703-A0AF-7B6DA0515344
P2860
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Fluorine-18-L-dihydroxyphenyla ...... hyperplasia in adult patients.
@en
Fluorine-18-L-dihydroxyphenylalanine
@nl
type
label
Fluorine-18-L-dihydroxyphenyla ...... hyperplasia in adult patients.
@en
Fluorine-18-L-dihydroxyphenylalanine
@nl
prefLabel
Fluorine-18-L-dihydroxyphenyla ...... hyperplasia in adult patients.
@en
Fluorine-18-L-dihydroxyphenylalanine
@nl
P2093
P356
P1476
Fluorine-18-L-dihydroxyphenyla ...... hyperplasia in adult patients
@en
P2093
Anna Salonen
Jorma Salmi
Jörgen Bergman
Kalle Alanen
Marko Seppänen
Matti Välimäki
Olof Solin
Pirjo Nuutila
Riitta Parkkola
Risto Gullichsen
P304
P356
10.1210/JC.2006-1479
P407
P50
P577
2007-01-16T00:00:00Z